Dublin, Ireland

Adrian Bracken

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Provost, Fellows, Scholars and Other Members of Board of Trinity College Dublin, Trinity College Dublin, University College Dublin. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Bracken. Retrieved from https://idiyas.com/inventor/adrian-bracken

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adrian Bracken: Innovator in Cancer Recurrence Prediction

Introduction

Adrian Bracken is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of cancer research, particularly in predicting the risk of cancer recurrence. His innovative approach has the potential to impact patient care and treatment strategies.

Latest Patents

Adrian Bracken holds a patent for a method of predicting the risk of recurrence of cancer. This method involves assaying a cancer sample from an individual for positive expression of at least two genes or proteins. The genes selected include FOXM1, UHRF1, PTTG1, E2F1, MYBL2, HMGB2, ATAD2, E2F8, ZNF367, and TCF19. Positive expression of these genes correlates with an increased risk of cancer recurrence compared to individuals who do not exhibit such expression. This patent represents a significant advancement in personalized medicine.

Career Highlights

Throughout his career, Adrian has worked with prestigious institutions, including Trinity College Dublin and University College Dublin. His work in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in cancer biology.

Collaborations

Adrian has collaborated with notable colleagues such as Fiona Lanigan and William Gallagher. Their combined expertise has fostered a productive research environment, leading to advancements in understanding cancer recurrence.

Conclusion

Adrian Bracken's innovative work in predicting cancer recurrence exemplifies the importance of research in improving patient outcomes. His contributions to the field are invaluable and highlight the potential of genetic analysis in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…